Ocata Therapeutics Inc (NASDAQ:OCAT)

6.14
Delayed Data
As of Mar 27
 -0.06 / -0.97%
Today’s Change
4.95
Today|||52-Week Range
12.73
+0.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues725.0K506.4K466.5K225.0K
 
 
 
 
 
Cost of Goods Sold78.6K276.8K58.8K39.9K
 
 
 
 
 
Depreciation And Amortization138.1K67.2K58.6K93.5K
 
 
 
 
 
 
Operating ExpensesGross Income508.4K162.5K349.1K91.5K
 
 
 
 
 
General Expenses23.9M21.0M21.8M24.6M
 
 
 
 
 
Other Operating Expenses-2.2M0.000.000.00
 
 
Research And Development8.4M10.0M11.4M11.7M
 
 
 
 
 
Total Operating Expenses21.9M21.4M21.9M24.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.2M-20.9M-21.5M-24.5M
 
 
 
 
 
Extraordinary Credit197.4K11.4M889.9K1.7M
 
 
 
 
 
Extraordinary Charge-17.3M-294.1K-7.2M-7.1M
 
 
 
 
 
Interest Expense On Debt11.7M1.5M1.1M1.4M
 
 
 
 
 
Equity In Earnings0.00-820.0K0.000.00
 
 
Other Expenses-4.3M-60.8M-17.1K160.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-54.4M-72.0M-28.5M-31.0M
 
 
 
 
 
Preferred Dividend-197.0K0.000.000.00
 
 
Net Income-54.4M-72.8M-28.5M-31.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.2M15.8M20.9M24.9M
 
 
 
 
 
Shares To Calculate EPS Diluted12.2M15.8M20.9M24.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.00-$5.00-$1.00-$1.00
 
 
 
 
 
EPS Diluted-$4.00-$5.00-$1.00-$1.00
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account